BdgluvBURIAEpUP |
VHYIJYdHeFb [2022-03-26] |
I'm a trainee http://msmcf.co.kr/pharmacy/stmap_15dawbxe.html?viagra.prometrium.meclizine men's rogaine vs women's rogaine And now, the drug has reached a key milestone: success in a Phase III trial eyeing Xtandi as a prechemo treatment for advanced prostate cancer. Independent monitors called for a halt, to allow patients in the control arm to receive Xtandi, too. According to the companies, Xtandi cut the risk of death by 30%, bringing overall survival to an estimated median of 32.4 months, compared with 30.2 months for patients in the placebo arm. The actual stats will be unveiled at a conference at some point.
|
|
|